At a glance
- Originator Scios
- Class Aminobenzoic acids; Anti-inflammatories; Antirheumatics; Fluorenes; Small molecules
- Mechanism of Action Immunosuppressants; Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rheumatoid arthritis; Ulcerative colitis
Most Recent Events
- 16 Jul 1998 No-Development-Reported for Rheumatoid arthritis in USA (Unknown route)
- 16 Jul 1998 No-Development-Reported for Ulcerative colitis in USA (Unknown route)
- 01 Jun 1995 Rhone-Poulenc Rorer is developing NPC 17923 in the USA